Not a good buy right now for an impatient entry: price is pressing into a key resistance zone (R2 ~67.68) while short-term momentum is overbought (RSI_6 ~82.8), which raises near-term pullback risk.
Trend is still bullish (moving averages stacked bullish + MACD expanding), so it’s a hold/keep on watch, but the current level looks stretched for immediate upside.
Positioning/sentiment is mixed: options open interest leans defensive (more puts outstanding), while day-of volume skews to calls but is small—doesn’t strongly confirm a breakout buy.
Technical Analysis
Trend/Momentum: Bullish structure with SMA_5 > SMA_20 > SMA_200, and MACD histogram +0.35 and expanding, supporting an ongoing uptrend.
Overbought condition:RSI_6 ~82.75 signals a crowded short-term move; buying here is statistically prone to a near-term mean reversion.
Levels: Pivot ~62.34 (key reference). Resistance at R1 ~65.64 has been surpassed; price is now near R2 ~67.68 (premarket ~67.63), a logical stalling/rejection zone.
Near-term bias: Pattern-based projection suggests ~70% chance of -0.26% next day, but positive bias over 1 week (+1.49%) and 1 month (+4.74%), implying upside may be better after consolidation rather than immediate chase.
Options Data
Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Sentiment (OI): Put-heavy open interest (PCR 1.41) suggests more hedging/defensive positioning outstanding.
Sentiment (today’s flow): Put/call volume ratio 0.15 indicates call volume dominated today, but total volume is low (23), so signal strength is limited.
Volatility: IV (30d) ~30.06 vs historical vol ~36.19, with IV percentile ~15.94 / IV rank ~6.82 → options are relatively cheap vs recent history, but not necessarily indicating an imminent catalyst.
Activity: Today’s volume vs 30D avg is elevated, but off a low base; not a clear “institutional rush” read.
Technical Summary
Sell
3
Buy
10
Positive Catalysts
Analyst price targets were raised across multiple firms after the earnings report, reinforcing a constructive medium-term narrative.
Company commentary/expectations point to positive pricing across segments into fiscal 2026 (supports margins and revenue quality).
Technical trend remains broadly bullish (MA stack + positive MACD), which can support continuation after a pause.
Neutral/Negative Catalysts
increase the risk of a near-term dip—unfavorable for an immediate buy.
Profitability: Net income 29.731M, down sharply YoY; EPS 0.54, also down sharply YoY (weak earnings trend in the quarter).
Margins: Gross margin 31.99% (+9.07% YoY), indicating pricing/mix and/or cost actions are helping margin quality even as revenue softens.
Takeaway: margin execution looks improved, but growth/earnings volatility remains a key concern.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend: On 2026-01-16, multiple firms raised price targets after the fiscal Q4 report.
Ratings mix: Predominantly Buy (Citi, Deutsche Bank, Seaport), with UBS Neutral (and UBS had initiated Neutral earlier).
Pros (Wall Street view): Pricing expected to be positive; margin momentum continues; some see attractive upside to higher PTs.
Cons (Wall Street view): Organic/volume growth is the main debate—several notes explicitly caution that volume improvement is not yet clear.
Overall: Street is constructive on profitability/pricing, but not fully confident on growth—consistent with a hold rather than a chase-buy at resistance.
Wall Street analysts forecast FUL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FUL is 70 USD with a low forecast of 60 USD and a high forecast of 80 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
Wall Street analysts forecast FUL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FUL is 70 USD with a low forecast of 60 USD and a high forecast of 80 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 65.390
Low
60
Averages
70
High
80
Current: 65.390
Low
60
Averages
70
High
80
Citi
Patrick Cunningham
Buy
maintain
$70 -> $76
AI Analysis
2026-01-16
Reason
Citi
Patrick Cunningham
Price Target
$70 -> $76
AI Analysis
2026-01-16
maintain
Buy
Reason
Citi analyst Patrick Cunningham raised the firm's price target on H.B. Fuller to $76 from $70 and keeps a Buy rating on the shares following the earnings report. The company expects positive pricing across all segments in fiscal 2026, the analyst tells investors in a research note.
UBS
Neutral
maintain
$60 -> $66
2026-01-16
Reason
UBS
Price Target
$60 -> $66
2026-01-16
maintain
Neutral
Reason
UBS raised the firm's price target on H.B. Fuller to $66 from $60 and keeps a Neutral rating on the shares. H.B. Fuller's 2026 outlook could be achievable if volume improvements materialize, the analyst tells investors in a research note.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for FUL
